Skip to main content
Premium Trial:

Request an Annual Quote

Centogene: New CentoGenome

Centogene has launched New CentoGenome, a diagnostic whole-genome sequencing test for patients with rare and neurodegenerative disorders. The test, which uses a PCR-free approach, covers almost all disease-causing variants, according to the firm, including certain repeat expansions, copy number variants associated with spinal muscular atrophy, and complex variants associated with Gaucher disease and GBA1-related Parkinson's disease.